Frontlight ResearchEarly access
Taking people in United StatesNo phase
Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study
Key facts
- Who runs it
- University of California, Davis
- Where
- Sacramento, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 50 people, planned
- Started
- Sept 2006
- Expected to end
- Jan 2040
- Type of study
- Observational
- Record updated
- 5 December 2025
Who can take part
- Age
- 1 Minute to 18 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- 18 years of age or younger at the onset of disease
- Presence of Vascular Thrombosis
- UC Davis patient
- Presence of at least one Laboratory criteria including: Anticardiolipin antibody, Anti-B glycoprotein-I antibody or Lupus anticoagulant in plasma
Who cannot take part
- Infants born to mothers with APS
- Infants with congenital thrombophilia
Where in United States
- UC Davis Medical CenterSacramento, United StatesContact: Lavjay ButaniTaking people
About the trial
What the trial wants to find out
The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 5 December 2025